Table 3.
Viral Suppression Outcomes of Virginia AIDS Drug Assistance Program Clients who Demonstrated Engagement in Care in 2014 and 2015 (Cohort B): Frequencies and Results of Univariable and Multivariable Binary Logistic Regression
| Characteristic/Factor | Good Viral Outcome, No. (Row %) | Unadjusted OR (95% CI) | P Value | Adjusted OR (95% CI) | P Value |
|---|---|---|---|---|---|
| All | 2056 (82.2) | NA | NA | NA | NA |
| 2015 ADAP program | .04 | .04 | |||
| ADAP-funded QHP | 1395 (83.3) | 1.25 (1.02–1.55) | 1.27 (1.01–1.60) | ||
| Direct ADAP | 661 (79.9) | Reference | Reference | ||
| Initial viral suppression (2014) | <.001 | <.001 | |||
| Undetectable | 1660 (87.6) | 3.78 (3.05–4.69) | 2.69 (2.13–3.39) | ||
| Detectable | 396 (65.2) | Reference | Reference | ||
| Age, y | <.001 | .01 | |||
| 18–24 | 110 (73.8) | 0.36 (0.23–0.58) | 0.52 (0.31–0.87) | ||
| 25–34 | 354 (76.1) | 0.41 (0.29–0.59) | 0.53 (0.36–0.78) | ||
| 35–44 | 467 (82.5) | 0.61 (0.42–0.87) | 0.75 (0.51–1.10) | ||
| 45–54 | 728 (83.4) | 0.65 (0.46–0.91) | 0.75 (0.53–1.07) | ||
| 55–64 | 397 (88.6) | Reference | Reference | ||
| Race/ethnicity | .06 | .5 | |||
| American Indian/Alaska Native/Native Hawaiian | 18 (94.7) | 3.47 (0.46–26.31) | 6.57 (0.83–52.22) | ||
| Asian | 36 (87.8) | 1.39 (0.53–3.62) | 1.12 (0.41–3.04) | ||
| Black/African American | 1287 (80.7) | 0.81 (0.63–1.03) | 1.09 (0.83–1.44) | ||
| Hispanic/Latino | 171 (86.8) | 1.27 (0.80–2.02) | 1.19 (0.72–1.96) | ||
| White | 544 (83.8) | Reference | Reference | ||
| Gender | .03 | .03 | |||
| Female | 578 (80.7) | 0.86 (0.69–1.07) | 0.79 (0.62–1.02) | ||
| Transgender | 11 (61.1) | 0.32 (0.12–0.87) | 0.32 (0.11–0.91) | ||
| Male | 1467 (83.0) | Reference | Reference | ||
| HIV/AIDS diagnosis | .2 | .004 | |||
| HIV diagnosis | 1308 (82.9) | 1.13 (0.92–1.40) | 1.41 (1.12–1.78) | ||
| AIDS diagnosis | 748 (81.0) | Reference | Reference | ||
| Financial status | <.001 | .004 | |||
| 251%–400% FPL (tax credit) | 198 (89.6) | 2.30 (1.47–3.61) | 1.97 (1.23–3.17) | ||
| 139%–250% FPL (tax credit) | 508 (86.1) | 1.66 (1.27–2.16) | 1.51 (1.30–2.00) | ||
| 101%–138% FPL (Medicaid gap with tax credit) | 253 (84.3) | 1.44 (1.03–2.01) | 1.20 (0.84–1.72) | ||
| <100% FPL (Medicaid gap, no tax credit) | 1097 (78.9) | Reference | Reference | ||
| Region of residence | <.001 | <.001 | |||
| Northwest | 285 (88.5) | 1.10 (0.73–1.65) | 1.13 (0.74–1.74) | ||
| Eastern | 309 (64.2) | 0.26 (0.19–0.34) | 0.40 (0.29–0.55) | ||
| Central | 569 (85.3) | 0.83 (0.61–1.13) | 0.99 (0.71–1.38) | ||
| Southwest | 274 (84.6) | 0.78 (0.54–1.13) | 0.95 (0.63–1.42) | ||
| Northern | 619 (87.6) | Reference | Reference | ||
| Days observed | <.001 | .3 |
Abbreviations: ADAP, AIDS Drug Assistance Program; CI, confidence interval; FPL, Federal Poverty Level; QHP, Qualified Health Plan.